No Effect of Aprotinin (Trasylol™) on Degradation of Exogenous and Endogenous Glucagon in Human, Mouse and Rat Plasma
Journal Title: Journal of Endocrinology and Diabetes - Year 2014, Vol 1, Issue 1
Abstract
Traditionally, aprotinin (Trasylol™) has been added to plasma samples prior to glucagon analysis. However, the evidence for the need of aprotinin is sparse and based on results obtained when radioimmunoassay (RIA) techniques were still in their infancy. Using RIAs directed against both the C-terminus and a mid-region of glucagon, we challenged the classical view that aprotinin is necessary. Glucagon concentrations in pools of human, mouse and rat plasma (n=30, 25 and 16 of each, respectively) with and without addition of increasing amounts of exogenous glucagon (5, 10, 20, 40 and 60 pM) were similar irrespective of whether or not aprotinin had been added. To investigate whether individual variation occurs in human samples, we measured plasma from 20 patients with gastrointestinal diseases and 20 healthy subjects with or without addition of aprotinin. Again, measured amounts of glucagon, endogenous or added, were not affected by the presence of aprotinin. The effect of aprotinin, present at blood sampling or added later (30 and 60 minutes), on endogenous glucagon values was investigated in T2DM patients (n=5), before and after insulin-induced hypoglycemia. There were no differences between the four treatments. In conclusion, we found no support for use of aprotinin for prevention of glucagon degradation.
Authors and Affiliations
Jens Juul Holst, Monika J Bak, Nicolai Wewer Albrechtsen, Jens Pedersen, Bolette Hartmann, Mikkel Christensen, Tina Vilsbøll, Filip Knop, Lars O Dragsted
Keywords
Related Articles
- EP ID EP332837
- DOI 10.15226/2374-6890/1/1/00101
- Views 113
- Downloads 0
The Possible Role of New Basal Insulin Analogues in Pediatric Population
In the pediatric age HbA1c values below 7.5% represent the ideal metabolic and glicemic target in DMT1 patients, but the literature shows that many of them are still very far from reaching this goal. The introduction of...
Association of Mean Platelet Volume and Platelet Distribution Width with Hba1c
Diabetes mellitus type 2 (DMT2) is a metabolic disorder, and its prevalence is rising worldwide. The objective of the study was to investigate association of mean platelet volume (MPV) and platelet distribution width (PD...
Extra-Skeletal and Endocrine Functions and Toxicity of Vitamin D
During the past 15 years, the knowledge related to vitamin D has markedly expanded, especially with reference to the hormonal and extra-skeletal effects of vitamin D. The understanding of the biological and physiological...
Phenotypical Classification of Type 2 Diabetes Mellitus
Obesity is believed to be the major contributing factor for type 2 diabetes. Obese subjects have 2-3 fold higher risk of developing type 2 diabetes. Obesity in type 2 diabetes increases the risk of hypertension, dyslipid...
A Systematic Review of Metabolite Profiling in Diabetic Nephropathy
In recent years, the incidence of diabetic nephropathy (DN) is in sharply rising trend. It is a great challenge for health care professionals to prevent the DN.As the tool of modern bioinformatics research, metabonomics...